Ready or Not

Biogenerics are on their way—with or without biotech’s blessing.

On the heels of President George W. Bush’s announcement of new rules from the U.S. Food and Drug Administration to speed small-molecule generic drugs to market, the race is on for the next generation of potential generics: biologics.

News Analysis

» Ready or Not

Vive la Differentiation!

Shrinking Staffs

Double Attack

Bull’s-Eye?

Biotech Buys

Sniffing for SNPs